12/01/2022
Researchers say they've identified a set of biomarkers that could make early diagnosis of Lyme disease easier, a possible first step for more effectively treating the estimated 476,000 people diagnosed with, and treated for, the tick-borne illness every year in the United States.
A genetic test would be an improvement on current FDA-approved tests, which identify antibodies that can take weeks to emerge.